Vimarsana
Biggest News Aggregation in the World

Page 5 - Detection Kit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Detection Kit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Detection Kit Today - Breaking & Trending Today

At-home drug detection kits could combat uptick in overdoses during holidays - Vimarsana News

At-home drug detection kits could combat uptick in overdoses during holidays

It's the most wonderful time of the year for some, but for others, it could be the most dangerous due to an uptick in drug overdoses during the holidays. However, an innovative tool could be used to combat the problem.

Source: yahoo.com
AmoyDx and CST Expand Existing Partnership for the Development of Companion Diagnostics (CDx) to Support Precision Oncology - Vimarsana News

AmoyDx and CST Expand Existing Partnership for the Development of Companion Diagnostics (CDx) to Support Precision Oncology

Cell Signaling Technology (CST), a life science biotechnology company and leading provider of antibodies, kits, and services, and Amoy Diagnostics Co., Ltd. (AmoyDx), a China-based innovative molecular diagnostics company in the field of precision oncology, announced today the expansion of their ongoing partnership for companion diagnostic (CDx) development in China.

FDA Approves RAS Mutation Detection Kit as Companion Diagnostic for Panitumumab in mCRC - Vimarsana News

FDA Approves RAS Mutation Detection Kit as Companion Diagnostic for Panitumumab in mCRC

The FDA has approved the CRCdx RAS Mutation Detection Kit as a companion diagnostic for panitumumab in the treatment of patients with metastatic colorectal cancer (mCRC), according to an announcement from EntroGen.

Source: ajmc.com
FDA Approves RAS Mutation Detection Kit as Companion Diagnostic for Panitumumab in mCRC - Vimarsana News

FDA Approves RAS Mutation Detection Kit as Companion Diagnostic for Panitumumab in mCRC

The FDA has approved the CRCdx® RAS Mutation Detection Kit as a companion diagnostic for panitumumab in the treatment of patients with metastatic colorectal cancer, according to an announcement from EntroGen.

COLOTECT 1.0 receives market authorization from Malaysia's Medical Device Authority - Vimarsana News

COLOTECT 1.0 receives market authorization from Malaysia's Medical Device Authority

Recently, BGI Genomics' COLOTECT 1.0 DNA Methylation Detection Kit for Human SDC2, ADHFE1, and PPP2R5C Genes (Real-Time PCR), Sample Pretreatment Kit for Methylation Detection, DNA Isolation Kit, Stool Sample Collection Kit have received market authorization from Malaysia's Medical Device Authority (hereinafter referred to as MDA).